Published in Proc Natl Acad Sci U S A on August 02, 2005
Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci (2008) 5.54
A unified framework for addiction: vulnerabilities in the decision process. Behav Brain Sci (2008) 2.83
Role of ventral medial prefrontal cortex in incubation of cocaine craving. Neuropharmacology (2008) 1.99
Relation of addiction genes to hypothalamic gene changes subserving genesis and gratification of a classic instinct, sodium appetite. Proc Natl Acad Sci U S A (2011) 1.89
Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving. Biol Psychiatry (2009) 1.48
Role of BDNF and GDNF in drug reward and relapse: a review. Neurosci Biobehav Rev (2009) 1.31
Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis. J Neurosci (2009) 1.12
The effects of aerobic exercise on cocaine self-administration in male and female rats. Psychopharmacology (Berl) (2011) 1.08
Heroin self-administration: II. CNS gene expression following withdrawal and cue-induced drug-seeking behavior. Pharmacol Biochem Behav (2008) 1.07
Incubation of methamphetamine and palatable food craving after punishment-induced abstinence. Neuropsychopharmacology (2014) 1.03
Cocainomics: new insights into the molecular basis of cocaine addiction. J Neuroimmune Pharmacol (2010) 0.92
Assessment of genome and proteome profiles in cocaine abuse. Prog Brain Res (2006) 0.90
Increased expression of protein kinase A inhibitor alpha (PKI-alpha) and decreased PKA-regulated genes in chronic intermittent alcohol exposure. Brain Res (2007) 0.89
Cocaine-mediated microglial activation involves the ER stress-autophagy axis. Autophagy (2015) 0.88
Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats. Mol Neurodegener (2014) 0.87
Biomarkers for the development of new medications for cocaine dependence. Neuropsychopharmacology (2013) 0.87
A potential role for adiponectin receptor 2 (AdipoR2) in the regulation of alcohol intake. Brain Res (2010) 0.85
Repeated amphetamine administration induces Fos in prefrontal cortical neurons that project to the lateral hypothalamus but not the nucleus accumbens or basolateral amygdala. Psychopharmacology (Berl) (2007) 0.85
Gene expression profiling reveals distinct cocaine-responsive genes in human fetal CNS cell types. J Addict Med (2009) 0.84
Integrative proteomic analysis of the nucleus accumbens in rhesus monkeys following cocaine self-administration. Mol Psychiatry (2008) 0.84
Cocaine potentiates excitatory drive in the perifornical/lateral hypothalamus. J Physiol (2012) 0.84
Long-term cocaine self-administration under fixed-ratio and second-order schedules in monkeys. Psychopharmacology (Berl) (2007) 0.82
MeCP2 regulates ethanol sensitivity and intake. Addict Biol (2013) 0.81
Inactivation of the central nucleus of the amygdala reduces the effect of punishment on cocaine self-administration in rats. Eur J Neurosci (2012) 0.80
A sensitizing D-amphetamine dose regimen induces long-lasting spinophilin and VGLUT1 protein upregulation in the rat diencephalon. Neurosci Lett (2009) 0.78
Hypothalamic proteoglycan syndecan-3 is a novel cocaine addiction resilience factor. Nat Commun (2013) 0.78
Cocaine modulates mammalian circadian clock timing by decreasing serotonin transport in the SCN. Neuroscience (2014) 0.76
Cocaine-mediated downregulation of microglial miR-124 expression involves promoter DNA methylation. Epigenetics (2016) 0.75
Chronic alcohol consumption from adolescence-to-adulthood in mice--hypothalamic gene expression changes in the dilated cardiomyopathy signaling pathway. BMC Neurosci (2014) 0.75
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 82.89
Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A (2001) 68.44
Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 52.74
KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res (1999) 40.62
Identifying biological themes within lists of genes with EASE. Genome Biol (2003) 31.72
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron (1994) 11.44
Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology (2001) 9.25
Gene expression profile of aging and its retardation by caloric restriction. Science (1999) 8.06
NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol (2001) 6.96
Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol (1954) 6.65
Transition from moderate to excessive drug intake: change in hedonic set point. Science (1998) 5.66
Drug seeking becomes compulsive after prolonged cocaine self-administration. Science (2004) 4.20
Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nat Genet (1996) 4.19
NF1 tumor suppressor gene function: narrowing the GAP. Cell (2001) 4.11
Neuroscience of addiction. Neuron (1998) 3.60
Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci (1999) 3.54
Cerebral hemisphere regulation of motivated behavior. Brain Res (2000) 3.53
Dramatic decreases in brain reward function during nicotine withdrawal. Nature (1998) 3.21
Glutamate-receptor-interacting protein GRIP1 directly steers kinesin to dendrites. Nature (2002) 3.16
Addictive drugs and brain stimulation reward. Annu Rev Neurosci (1996) 3.12
Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature (2002) 3.05
Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev (2004) 2.97
Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci (2002) 2.83
Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity. Neuron (2004) 2.76
Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology (1991) 2.41
A comparison of statistical methods for analysis of high density oligonucleotide array data. Bioinformatics (2003) 2.20
Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci U S A (1995) 2.00
Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J Neurosci (2000) 1.99
Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav (1992) 1.96
Deletion of the neuron-specific protein delta-catenin leads to severe cognitive and synaptic dysfunction. Curr Biol (2004) 1.80
Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol (2003) 1.80
Increased motivation for self-administered cocaine after escalated cocaine intake. Neuroreport (2003) 1.73
Neurofibromin regulates G protein-stimulated adenylyl cyclase activity. Nat Neurosci (2002) 1.58
Characterization of the glutamate receptor-interacting proteins GRIP1 and GRIP2. J Neurosci (1999) 1.55
Escalation of cocaine self-administration does not depend on altered cocaine-induced nucleus accumbens dopamine levels. J Neurochem (2003) 1.52
Gene expression profiles predict survival and progression of pleural mesothelioma. Clin Cancer Res (2004) 1.51
Rapid increase in clusters of presynaptic proteins at onset of long-lasting potentiation. Science (2001) 1.51
Hemizygosity of delta-catenin (CTNND2) is associated with severe mental retardation in cri-du-chat syndrome. Genomics (2000) 1.47
Dendrite-like process formation and cytoskeletal remodeling regulated by delta-catenin expression. Exp Cell Res (2002) 1.45
The evolutionary pressure to inactivate. A subclass of synaptotagmins with an amino acid substitution that abolishes Ca2+ binding. J Biol Chem (1997) 1.44
Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol (2000) 1.38
Identification of subunits contributing to synaptic and extrasynaptic NMDA receptors in Golgi cells of the rat cerebellum. J Physiol (2000) 1.37
Association of AMPA receptors with a subset of glutamate receptor-interacting protein in vivo. J Neurosci (1999) 1.37
Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther (1994) 1.35
Slow deactivation kinetics of NMDA receptors containing NR1 and NR2D subunits in rat cerebellar Purkinje cells. J Physiol (2000) 1.31
Modulation of synaptic transmission by the BCL-2 family protein BCL-xL. J Neurosci (2003) 1.28
Glutamate transmission and addiction to cocaine. Ann N Y Acad Sci (2003) 1.25
Recent advances in neurofibromatosis type 1. Curr Opin Neurol (2004) 1.23
Expressing what's on your mind: DNA arrays and the brain. Nat Rev Neurosci (2001) 1.18
The G protein beta subunit is a determinant in the coupling of Gs to the beta 1-adrenergic and A2a adenosine receptors. J Biol Chem (2001) 1.17
Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation. Neuroscience (2001) 1.13
Selective breeding, quantitative trait locus analysis, and gene arrays identify candidate genes for complex drug-related behaviors. J Neurosci (2003) 1.12
Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J Neurosci (1992) 1.10
Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Psychopharmacology (Berl) (2000) 1.07
G-protein beta-subunit specificity in the fast membrane-delimited inhibition of Ca2+ channels. J Neurosci (1998) 1.04
Glutamate-induced delta-catenin redistribution and dissociation from postsynaptic receptor complexes. Neuroscience (2002) 1.02
Expression profiling identifies strain-specific changes associated with ethanol withdrawal in mice. Genes Brain Behav (2002) 1.02
Dissecting tBHQ induced ARE-driven gene expression through long and short oligonucleotide arrays. Physiol Genomics (2004) 1.01
Conditioned facilitation of brain reward function after repeated cocaine administration. Behav Neurosci (2003) 0.94
Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase. J Biol Chem (2000) 0.93
Potentiation of lateral hypothalamic and midline mesencephalic brain stimulation reinforcement by nicotine: examination of repeated treatment. J Pharmacol Exp Ther (1994) 0.93
Time-dependent alterations in ICSS thresholds associated with repeated amphetamine administrations. Pharmacol Biochem Behav (2000) 0.90
Evidence for an allelic association between bipolar disorder and a Na+, K+ adenosine triphosphatase alpha subunit gene (ATP1A3). Biol Psychiatry (1998) 0.90
Brain-stimulation reward: a review. Can J Psychol (1991) 0.90
Glutamate receptor-interacting protein 1 protein binds to the microtubule-associated protein. Biosci Biotechnol Biochem (2004) 0.89
rGbeta1: a psychostimulant-regulated gene essential for establishing cocaine sensitization. J Neurosci (1997) 0.86
A slow NMDA channel: in search of a role. J Physiol (2000) 0.80
Cocaine-induced expression differences in PSD-95/SAP-90-associated protein 4 and in Ca2+/calmodulin-dependent protein kinase subunits in amygdalae of taste aversion-prone and taste aversion-resistant rats. Ann N Y Acad Sci (2003) 0.78
The role of intrinsic neurons in lateral hypothalamic self-stimulation. Behav Brain Res (1986) 0.78
Axonal contact regulates expression of alpha2 and beta2 isoforms of Na+, K+-ATPase in Schwann cells: adhesion molecules and nerve regeneration. J Neurochem (1997) 0.78
Cocaine's long run. Nat Med (2004) 0.77
The diencephalic peninsula: self-stimulation after unilateral precollicular transection and removal of the telencephalon. Brain Res (1982) 0.76
Intrinsic neurons are involved in lateral hypothalamic self-stimulation. Brain Res (1983) 0.76
Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatment. Alcohol Clin Exp Res (2015) 4.94
Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcohol Clin Exp Res (2004) 3.19
A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci (2007) 3.16
Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci (2006) 3.13
Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res (2002) 3.11
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A (2005) 3.05
Toward understanding the genetics of alcohol drinking through transcriptome meta-analysis. Proc Natl Acad Sci U S A (2006) 3.04
Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev (2004) 2.97
Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci (2002) 2.83
Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci (2006) 2.74
Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry (2006) 2.70
Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology (2007) 2.61
Glutamatergic neurons are present in the rat ventral tegmental area. Eur J Neurosci (2007) 2.53
Measuring meals: structure of prandial food and water intake of rats. Am J Physiol Regul Integr Comp Physiol (2005) 2.32
Escalation of methamphetamine self-administration in rats: a dose-effect function. Psychopharmacology (Berl) (2006) 2.24
The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) (2010) 2.19
Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. Eur J Neurosci (2009) 2.11
Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence. Biol Psychiatry (2010) 2.04
CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc Natl Acad Sci U S A (2007) 2.01
The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol Clin Exp Res (2007) 1.99
Alcohol-related genes: contributions from studies with genetically engineered mice. Addict Biol (2006) 1.95
Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation. J Pharmacol Exp Ther (2004) 1.92
Mesocorticolimbic glutamatergic pathway. J Neurosci (2011) 1.92
Cellular and behavioral interactions of gabapentin with alcohol dependence. J Neurosci (2008) 1.91
Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Rep (2012) 1.91
Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1. Proc Natl Acad Sci U S A (2003) 1.89
Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region. J Neurosci (2002) 1.85
Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function. Psychopharmacology (Berl) (2005) 1.82
Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J Neurosci (2010) 1.82
Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol (2003) 1.81
Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur J Neurosci (2008) 1.81
Treating cocaine addiction with viruses. Proc Natl Acad Sci U S A (2004) 1.75
Neuroimmune regulation of alcohol consumption: behavioral validation of genes obtained from genomic studies. Addict Biol (2011) 1.75
Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J Neurosci (2007) 1.73
Stress enhancement of craving during sobriety: a risk for relapse. Alcohol Clin Exp Res (2005) 1.71
alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. Alcohol (2008) 1.71
Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. J Neurosci (2012) 1.65
Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol Biochem Behav (2007) 1.63
Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci Biobehav Rev (2010) 1.61
Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addict Biol (2011) 1.58
CRF system recruitment mediates dark side of compulsive eating. Proc Natl Acad Sci U S A (2009) 1.57
Preclinical studies of alcohol binge drinking. Ann N Y Acad Sci (2011) 1.56
Role of projections from ventral medial prefrontal cortex to nucleus accumbens shell in context-induced reinstatement of heroin seeking. J Neurosci (2012) 1.56
Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol Biochem Behav (2004) 1.56
Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci (2005) 1.53
Escalation of cocaine self-administration does not depend on altered cocaine-induced nucleus accumbens dopamine levels. J Neurochem (2003) 1.52
Drug addiction: pathways to the disease and pathophysiological perspectives. Eur Neuropsychopharmacol (2006) 1.48
Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving. Biol Psychiatry (2009) 1.48
A vaccine strategy that induces protective immunity against heroin. J Med Chem (2011) 1.47
Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats. Psychopharmacology (Berl) (2004) 1.47
The therapeutic potential of CRF1 antagonists for anxiety. Expert Opin Investig Drugs (2004) 1.46
Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction. Psychopharmacology (Berl) (2006) 1.45
Nicotine withdrawal in adolescent and adult rats. Ann N Y Acad Sci (2004) 1.44
Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access. Eur Neuropsychopharmacol (2007) 1.43
Effects of dose and session duration on cocaine self-administration in rats. J Pharmacol Exp Ther (2007) 1.42
The transition from controlled to compulsive drug use is associated with a loss of sensitization. Brain Res (2004) 1.40
MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacol Biochem Behav (2007) 1.39
Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic. J Comp Neurol (2008) 1.39
Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration. Neuropsychopharmacology (2007) 1.38
Operant behavior and alcohol levels in blood and brain of alcohol-dependent rats. Alcohol Clin Exp Res (2009) 1.37
Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) (2006) 1.37
Vapor inhalation of alcohol in rats. Curr Protoc Neurosci (2008) 1.37
Investigations using immunization to attenuate the psychoactive effects of nicotine. Bioorg Med Chem (2004) 1.37
Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation. Alcohol Clin Exp Res (2004) 1.36
Neurobiologic Advances from the Brain Disease Model of Addiction. N Engl J Med (2016) 1.36
CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats. Psychopharmacology (Berl) (2007) 1.35
Nibbling at CRF receptor control of feeding and gastrocolonic motility. Trends Pharmacol Sci (2003) 1.35
Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties. Brain Struct Funct (2012) 1.33
Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats. Behav Pharmacol (2008) 1.33
Recruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinking. Proc Natl Acad Sci U S A (2012) 1.33
Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine. Psychopharmacology (Berl) (2009) 1.32
Progress in corticotropin-releasing factor-1 antagonist development. Drug Discov Today (2010) 1.32
Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke (2003) 1.32
Methamphetamine self-administration and voluntary exercise have opposing effects on medial prefrontal cortex gliogenesis. J Neurosci (2007) 1.32
Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. Neuropsychopharmacology (2007) 1.31
Extended access to nicotine self-administration leads to dependence: Circadian measures, withdrawal measures, and extinction behavior in rats. J Pharmacol Exp Ther (2006) 1.30
Legionella contamination in hot water of Italian hotels. Appl Environ Microbiol (2005) 1.29
What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep (2004) 1.29
Unlimited access to heroin self-administration: independent motivational markers of opiate dependence. Neuropsychopharmacology (2006) 1.29
Neurobiology of alcohol dependence: focus on motivational mechanisms. Alcohol Res Health (2008) 1.29
A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Res (2007) 1.28
Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval. Neuropsychopharmacology (2006) 1.27
ERK regulation in chronic ethanol exposure and withdrawal. Brain Res (2002) 1.27
A critical evaluation of a nicotine vaccine within a self-administration behavioral model. Mol Pharm (2010) 1.26
Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol Clin Exp Res (2008) 1.25
'Nicotine deprivation effect' in rats with intermittent 23-hour access to intravenous nicotine self-administration. Pharmacol Biochem Behav (2007) 1.25
Dynamic vaccine blocks relapse to compulsive intake of heroin. Proc Natl Acad Sci U S A (2013) 1.24
NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice. Neuropsychopharmacology (2006) 1.24
Alcohol dependence as a chronic pain disorder. Neurosci Biobehav Rev (2012) 1.23
Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced increases in alcohol drinking. Pharmacol Biochem Behav (2008) 1.23
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology (2005) 1.23
Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats. Addict Biol (2009) 1.23
Neuropeptide Y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence. Biol Psychiatry (2011) 1.22
Neuroregenerative effects of BMP7 after stroke in rats. J Neurol Sci (2005) 1.22
Varied access to intravenous methamphetamine self-administration differentially alters adult hippocampal neurogenesis. Biol Psychiatry (2008) 1.21
Changes in response to a dopamine receptor antagonist in rats with escalating cocaine intake. Psychopharmacology (Berl) (2003) 1.21
Discharge profiles across the sleep-waking cycle of identified cholinergic, GABAergic, and glutamatergic neurons in the pontomesencephalic tegmentum of the rat. J Neurosci (2014) 1.21
A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions. J Neurosci (2009) 1.19
Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neurosci (2002) 1.19